With emergency use authorisation for J&J’s single-dose vaccine, the next step is to speed up its domestic production. As with reserving 30 crore doses of the under-trial Corbevax with Biological E, which is also reportedly...
from Times of India Opinion https://ift.tt/3xz7uxG
No comments:
Post a Comment